Switch to:
More From Other Websites
Would Pfizer Buying GlaxoSmithKline Make Sense? May 22 2015
Esperion Therapeutics: 15 Reasons to Take Profits May 22 2015
Could M&A Boost Pfizer More? Jefferies Thinks So May 22 2015
Jefferies Makes Changes to Top Pharmaceutical Stocks to Buy May 22 2015
In a quiet stock market, whispers of an M&A wave May 22 2015
Amgen first to win EU backing for new kind of cholesterol drug May 22 2015
All Eyes on Pfizer as Shareholders Await the Mega-Deal May 22 2015
All Eyes on Pfizer as Shareholders Await the Mega-Deal: Real M&A May 21 2015
How a "PfizerKline" would impact the Triangle May 21 2015
3 Big Pharmaceutical Stocks to Buy Right Now May 21 2015
Takeover talk sends FTSE higher May 20 2015
Hedge Funds Love These 5 Big Stocks -- but Should You? May 20 2015
How biotechs are affecting J&J's business May 20 2015
Pfizer To See Boosting Revenues On New Drugs Growth Through 2020 May 20 2015
Pfizer Would Benefit From Glaxo Takeover, Deutsche Bank Says May 20 2015
Who are Pfizer's (PFE) main competitors? May 20 2015
JNJ's 'balance approach' accounts for success: CEO May 20 2015
[$$] Merck Could Struggle to Hit Health Care Heights May 19 2015
Pfizer Invites Public to View and Listen to Webcast of June 2 Conference Call with Analysts to... May 19 2015
Pfizer Invites Public to View and Listen to Webcast of June 2 Conference Call with Analysts to... May 19 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

SEENSCO
ReplySEENSCO - 11 months ago
PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK